Usefulness of Reynolds Risk Score in men with stable angina

• Authors: Inga Pietka , Agata Sakowicz , Tadeusz Pietrucha , Anna Cichocka-Radwan , Malgorzata Lelonek
• Languages of publication: EN

Abstracts

EN

Keywords

EN

Reynolds Risk Score; Stable coronary artery disease; Men

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2014
• Volume: 9
• Issue: 1
• Pages: 21-27

Dates

published

1 - 2 - 2014

online

4 - 2 - 2014

Contributors

author

Inga Pietka

• Department of Cardiology, Chair of Cardiology and Cardiac Surgery, Medical University of Lodz, Poland, Sterling Str. 1/3, 91-425, Lodz, Poland

author

Agata Sakowicz

• Department of Medical Biotechnology, Medical University of Lodz, Poland, Zeligowskiego 7/9 Str., 90-752, Lodz, Poland

author

Tadeusz Pietrucha

• Department of Medical Biotechnology, Medical University of Lodz, Poland, Zeligowskiego 7/9 Str., 90-752, Lodz, Poland

author

Anna Cichocka-Radwan

• Department of Cardiology, Chair of Cardiology and Cardiac Surgery, Medical University of Lodz, Poland, Sterling Str. 1/3, 91-425, Lodz, Poland

author

Malgorzata Lelonek

• Department of Cardiology, Chair of Cardiology and Cardiac Surgery, Medical University of Lodz, Poland, Sterling Str. 1/3, 91-425, Lodz, Poland

References

• [1] Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL, Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation, 2004, 109(1): IV6–19
• [2] Hansson GK, Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005, 352,1685–1695 http://dx.doi.org/10.1056/NEJMra043430[Crossref]
• [3] Libby P, Theroux P, Pathophysiology of coronary artery disease. Circulation, 2005, 111,3481–3488 http://dx.doi.org/10.1161/CIRCULATIONAHA.105.537878[Crossref]
• [4] Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al., Centers for Disease Control and Prevention; American Heart Association, Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003, 107,499–511 http://dx.doi.org/10.1161/01.CIR.0000052939.59093.45[Crossref]
• [5] Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al., C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet, 2010, 375,132–140 http://dx.doi.org/10.1016/S0140-6736(09)61717-7[WoS][Crossref]
• [6] Ridker PM, Buring JE, Rifai N, Cook NR, Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA, 2007, 297,611–619 http://dx.doi.org/10.1001/jama.297.6.611[WoS][Crossref]
• [7] Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR, C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation, 2008, 118,2243–2245 http://dx.doi.org/10.1161/CIRCULATIONAHA.108.814251[Crossref]
• [8] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 2001, 285,2486–2497
• [9] Gohlke H, Winter M, Karoff M, Held K, CARRISMA: a new tool to improve risk stratification and guidance of patients in cardiovascular risk management in primary prevention. Eur J Cardiovasc Prev Rehabil, 2007, 14,141–148 http://dx.doi.org/10.1097/01.hjr.0000244581.30421.69[Crossref]
• [10] Collins GS, Altman DG, An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. Br Med J, 2009, 339,b2584–b2593 http://dx.doi.org/10.1136/bmj.b2584[Crossref]
• [11] Collins GS, Altman DG, An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. Br Med J, 2010, 340,c2442–c2450 http://dx.doi.org/10.1136/bmj.c2442[Crossref]
• [12] Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM, Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet, 2008, 371,923–931 http://dx.doi.org/10.1016/S0140-6736(08)60418-3[Crossref][WoS]
• [13] O’Donnell CJ, Elosua R, Cardiovascular risk factors. Insights from Framingham Heart Study. Rev Esp Cardiol, 2008, 61,299–310 [WoS]
• [14] Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al., Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol, 2002, 156, 871–881 http://dx.doi.org/10.1093/aje/kwf113[Crossref]
• [15] Okwuosa TM, Greenland P, Ning H, Liu K, Bild DE, Burke GL, Eng J, et al., Distribution of coronary artery calcium scores by Framingham 10-Year risk strata in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol, 2011, 57,1838–1845 http://dx.doi.org/10.1016/j.jacc.2010.11.053[Crossref]
• [16] DeFilippis AP, Blaha MJ, Ndumele CE, Budoff MJ, Lloyd-Jones DM, McClelland RL, et al., The association of Framingham and Reynolds Risk Scores with incidence and progression of coronary artery calcification in MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol, 2011,58,2076–2083 http://dx.doi.org/10.1016/j.jacc.2011.08.022[Crossref][WoS]
• [17] Heeschen C, Dimmeler S, Fichtlscherer S, Hamm CW, Berger J, Simoons ML, et al., CAPTURE Investigators, Prognostic value of placental growth factor in patients with acute chest pain. JAMA, 2004,291, 435–441 http://dx.doi.org/10.1001/jama.291.4.435[Crossref]
• [18] Lenderink T, Heeschen C, Fichtlscherer S, Dimmeler S, Hamm CW, Zeiher AM, et al., CAPTURE Investigators: Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol, 2006, 47,307–311 http://dx.doi.org/10.1016/j.jacc.2005.08.063[Crossref]
• [19] Silaghi AC, Pais R, Valea A, Mironiuc AI, Silaghi H, Epicardial adipose tissue and relationship with coronary artery disease. Centr Eur J Med, 2011, 6,251–262 http://dx.doi.org/10.2478/s11536-011-0011-7[Crossref][WoS]

Identifiers

DOI

10.2478/s11536-013-0240-z